About 52,500 results
Open links in new tab
  1. BRAF (gene) - Wikipedia

    BRAF is a human gene that encodes a protein called B-Raf. The gene is also referred to as proto-oncogene B-Raf and v-Raf murine sarcoma viral oncogene homolog B, while the protein is more …

  2. BRAF Mutation and Cancer - Johns Hopkins Medicine

    2 days ago · BRAF gene mutations can cause normal cells to become cancerous. Learn about the mutation, the types of cancer it can cause and the treatments available.

  3. BRAF

    Apr 16, 2024 · In this review, we cover the current understanding of BRAF mutations and associated clinical characteristics in patients with metastatic NSCLC, approved and emerging treatment options, …

  4. BRAF and Lung Cancer - American Lung Association

    Dec 2, 2025 · BRAF is one type of lung cancer biomarker. BRAF is the name of both a gene and a protein. The BRAF protein helps control cell growth. When there is a mutation in the BRAF gene, it …

  5. BRAF Mutation: Cancer Types, Testing, Treatment - Verywell Health

    Sep 15, 2025 · BRAF mutations are present in many melanomas as well as some lung cancers, colon cancers, and more. Learn about the basics, testing, and treatment.

  6. BRAF gene: MedlinePlus Genetics

    The BRAF gene provides instructions for making a protein that helps transmit chemical signals from outside the cell to the cell's nucleus. Learn about this gene and related health conditions.

  7. BRAF Gene - GeneCards | BRAF Protein | BRAF Antibody

    Jan 14, 2026 · BRAF (B-Raf Proto-Oncogene, Serine/Threonine Kinase) is a Protein Coding gene. Diseases associated with BRAF include Lung Cancer and Cardiofaciocutaneous Syndrome 1. …

  8. Biology and Clinical Management of Non-V600 BRAF Alterations

    Jan 19, 2026 · Beyond point mutations, other BRAF alterations (e.g., gene fusions, deletions, and amplifications) have been identified in treatment-naive tumors and in the context of acquired …

  9. FDA Approves Guardant360 CDx Diagnostic For Some With Colorectal …

    4 days ago · The FDA approved Guardant360 CDx as a companion diagnostic to identify patients with BRAF V600E-mutant metastatic colorectal cancer who may benefit from Braftovi with Erbitux and …

  10. Guardant Health Receives FDA Approval for Guardant360® CDx as …

    The accelerated approval was supported by data from Pfizer’s Phase 3 BREAKWATER trial, which evaluated encorafenib-based regimens in previously untreated patients with BRAF -mutated …